The leading type 1 diabetes (T1D) research and advocacy organization unveils its new identity to better reflect the community it serves while working to accelerate breakthroughs in T1D research TORONTO, […]
A joint response to Bill C-64, An Act Respecting Pharmacare, receiving Royal Assent from JDRF Canada and Diabetes Canada.
Ottawa, ON (October 11, 2024) – For the more than four million people living with diabetes in Canada, access to affordable medications is critical. As Bill C-64, An Act Respecting Pharmacare, […]
Research Canada Recognizes Three Champions of Health Research Advocacy
OTTAWA, September 26, 2024 – Research Canada is pleased to announce the 2024 Leadership in Advocacy Awardees. 2024 Leadership in Advocacy Awardee: Dr. Leena Augimeri, a Children/Youth Mental Wellness and Crime […]
JDRF Walk to Cure Diabetes
TORONTO, ON — May 31, 2024 – Throughout June close to 50 communities will be gathering across Canada to raise funds for type 1 diabetes research The JDRF Walk to […]
Newfoundland and Labrador expands access to continuous glucose monitoring program
March 21, 2024 – Newfoundland and Labrador – Through Budget 2024, the Government of Newfoundland & Labrador is expanding its continuous glucose monitoring program to include patients with type 1 […]
JDRF Proudly Announces the Appointment of New International Board of Directors Vice Chair
Matt Varey of Ontario is the first Canadian to serve as Vice Chair on the board of the global type 1 diabetes non-profit New York and Toronto, March 13, 2024 […]
Canadians living with type 1 diabetes will have improved access to the treatments and devices they need through a new national pharmacare program
February 29, 2024 – Ottawa – Today marks a historic moment for the type 1 diabetes (T1D) community in Canada. JDRF Canada is thrilled to have been part of the […]
Nova Scotia announces expanded coverage for insulin pumps and advanced glucose monitoring
February 28, 2024 – Halifax – The Government of Nova Scotia announced a historic investment to provide better access to diabetes devices such as insulin pumps and glucose monitors for […]
Ensuring Canadians living with diabetes have access to the treatments and devices they need in Canada’s national pharmacare program
February 27, 2024 – Canada-wide – JDRF Canada, an organization dedicated to improving the lives of the estimated 300,000 Canadians living with type 1 diabetes (T1D) through its advocacy efforts, […]
CIHR Research Excellence, Diversity, and Independence (REDI) Early Career Transition Awards Announced
These awards support the career development of the next generation of health researchers. The REDI awards are available to post-doctoral researchers, clinicians, and research associates from specific underrepresented groups to […]
JDRF Canada Op-Ed in the Hill Times, February 14, 2024
OPINION: Canada is on track to cure type 1 diabetes. With the right support, we can get there. Research innovation is becoming increasingly competitive in the post-pandemic world and Canada […]
JDRF Canada and Sanofi Canada partner to raise awareness about autoimmune type 1 diabetes and the critical role of screening in its early detection.
Toronto, Ontario, February 20, 2024 – JDRF Canada and Sanofi Canada are announcing a partnership aimed at amplifying awareness around type 1 diabetes (T1D), a chronic autoimmune condition, and the […]